Skip to main content
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.85
+0.03 (0.38%)
At close: Apr 28, 2026, 4:00 PM EDT
7.81
-0.04 (-0.51%)
Pre-market: Apr 29, 2026, 4:13 AM EDT

Ginkgo Bioworks Holdings Revenue

In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%. Ginkgo Bioworks Holdings had revenue of $33.40M in the quarter ending December 31, 2025, a decrease of -23.84%.

Revenue (ttm)
$170.16M
Revenue Growth
-25.06%
P/S Ratio
2.69
Revenue / Employee
$350,835
Employees
485
Market Cap
456.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025170.16M-56.89M-25.06%
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
REGENXBIO 170.44M
Assembly Biosciences 72.30M
Entrada Therapeutics 25.42M
Prelude Therapeutics 12.14M
Ovid Therapeutics 7.25M
Revenue Rankings

DNA News

More News